Pulmonary airflow obstruction following lymphography

Area of Science:

• Pulmonary Medicine
• Radiology

Background:

• Lymphography is a diagnostic imaging procedure.
• Oily contrast media are used in lymphography.
• Potential pulmonary side effects of lymphography are not fully understood.

Purpose of the Study:

• To investigate the impact of lymphography with oily contrast medium on lung function.
• To identify factors influencing changes in forced expiratory volume in one second (FEV1) post-lymphography.

Main Methods:

• A study involving 27 patients undergoing lymphography with oily contrast medium.
• Pulmonary function tests, specifically FEV1, were measured at various time points post-injection (0.5, 2, 4, and 24 hours).
• Analysis of factors such as contrast volume, injection speed, lymph node metastasis, and aspirin use on FEV1 changes.

Main Results:

• A significant mean decrease in FEV1 was observed at 0.5, 2, 4, and 24 hours after lymphography, peaking at 4 hours.
• Larger contrast volumes and higher injection speeds correlated with greater FEV1 decrease.
• Patients with metastatic lymph nodes showed a more pronounced FEV1 reduction, while aspirin administration was associated with a less marked decrease.
• No serious clinical side effects were reported.

Conclusions:

• Lymphography with oily contrast medium can transiently impair lung function, indicated by reduced FEV1.
• Risk factors for significant FEV1 decrease include high contrast volume, rapid injection, and lymph node metastases.
• Recommendations include limiting contrast administration and speed, particularly in patients with pre-existing severe airflow obstruction or lymphatic metastases.
• Aspirin may offer a protective effect against FEV1 reduction following lymphography.